Changing incentives to ACCELERATE drug development for paediatric cancer

BACKGROUND: More effective incentives are needed to motivate paediatric oncology drug development, uncoupling it from dependency on adult drug development. Although the current European and North‐American legislations aim to promote drug development for paediatrics and rare diseases, children and ad...

Descripción completa

Detalles Bibliográficos
Autores principales: de Rojas, Teresa, Kearns, Pamela, Blanc, Patricia, Skolnik, Jeffrey, Fox, Elizabeth, Knox, Leona, Rousseau, Raphael, Doz, François, Bird, Nick, Pearson, Andrew J., Vassal, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134303/
https://www.ncbi.nlm.nih.gov/pubmed/36645217
http://dx.doi.org/10.1002/cam4.5627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134303/
https://www.ncbi.nlm.nih.gov/pubmed/36645217
http://dx.doi.org/10.1002/cam4.5627

Ejemplares similares